Sign in

CIK 0001612940

  • Accelerated filer

ProQR Therapeutics N.V.

Sign in to watch
Ticker
PRQR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
Other
Phone
+31 881667000
Business address
ZERNIKEDREEF 9, LEIDEN, Netherlands
Former names
ProQR Therapeutics B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-31 de Boer Daniel Anton Chief Executive Officer Purchase +200,000 $1.77 $354K 500,000
2026-07-17 Filius Bart Director Purchase +150,000 $1.72 $258K 300,000
2026-07-09 de Boer Daniel Anton Chief Executive Officer Purchase +150,000 $1.74 $261K 300,000
2026-07-07 de Boer Daniel Anton Chief Executive Officer Purchase +150,000 $1.59 $239K 150,000
2026-06-26 Filius Bart Director Purchase +150,000 $1.54 $231K 150,000
2026-06-02 Hinsch Gylvin Lykke Director Grant or award · Share Option (Right to Buy) +14,595 14,595
2026-06-02 Hinsch Gylvin Lykke Director Grant or award · Share Option (Right to Buy) +14,495 14,495

Page 1 of 1 · 7 trades